4 insiders reported 12 Form 4 transactions for DAXOR CORP (DXR) over the past 18 months (most recent 2026-09-01). Recent activity: Jefferies John (Chief Medical Officer) Buy 2,451 shares, Feldschuh Michael Richard (Chief Executive Officer) Buy 30,000 shares, Michel Robert J (Chief Financial Officer) Buy 12,000 shares, Feldschuh Jonathan Adam (Chief Scientific Officer) Buy 25,000 shares, Feldschuh Michael Richard (Chief Executive Officer) Buy 1,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-01 | Jefferies John | Chief Medical Officer | Buy | 2,451 | $0 |
| 2026-06-25 | Feldschuh Michael Richard | Chief Executive Officer | Buy | 30,000 | $0 |
| 2026-06-25 | Michel Robert J | Chief Financial Officer | Buy | 12,000 | $0 |
| 2026-06-25 | Feldschuh Jonathan Adam | Chief Scientific Officer | Buy | 25,000 | $0 |
| 2026-04-10 | Feldschuh Michael Richard | Chief Executive Officer | Buy | 1,000 | $9,070 |
| 2026-03-31 | Michel Robert J | Chief Financial Officer | Buy | 1,000 | $9,900 |
| 2026-03-24 | Jefferies John | Chief Medical Officer | Buy | 3,656 | $0 |
| 2026-03-24 | Jefferies John | Chief Medical Officer | Buy | 2,285 | $0 |
| 2025-12-11 | Michel Robert J | Chief Financial Officer | Buy | 3,000 | $0 |
| 2025-12-11 | Feldschuh Jonathan Adam | Chief Scientific Officer | Buy | 18,000 | $0 |
| 2025-11-14 | Jefferies John | Chief Medical Officer | Buy | 2,344 | $0 |
| 2025-04-07 | Feldschuh Michael Richard | Chief Executive Officer | Buy | 2,063 | $16,277 |
来源：SEC Form 4 申报文件 · 截至 2026-09-01